Small RNAs add more years into your life: MiRNA-27a inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via down regulation of its target gene, 7/April/2015, 14.47

Natural product-based therapy for p53-deficient tumors: Cucurbitacin I (JSI-124) suppresses and increases the expression of DNp63α and IAPP(Amylin), respectively, and induces regression of p53-mutated human tumors via down regulation of its target gene, 7/April/2015, 13.01
April 7, 2015
Natural product-based Lifespan extension therapy: Isoflavones, found in soy foods, may prolong mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 7/April/2014, 21.24
April 7, 2015
Show all

A recent study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477by Prof Dominic J. Withers, Dr. Selman C and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMDreports that: Small RNAs add more years into your life: MiRNA-27a inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via down regulation of its target gene. 

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Small RNAs add more years into your life:  MiRNA-27a inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via down regulation of its target gene, 7/April/2015, 14.47, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests an MiRNA-based Life-span extension therapy. MiRNA-27a, by suppressing the expression of its target gene, it may decrease the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase). Thereby, it may promote (1) resistance to bone, immune, and motor dysfunction; and (2) insulin sensitivity.  Thus, pharmacological formulations encompassing MiRNA-27a or its activators may be used to extend the life span of an individual.

Undisclosed information: How MiRNA-27a decreases the expression of p70S6 Kinase

Comments are closed.